Buy Like Buffett

The Moat Index

Quarta-Rad, Inc.

QURT · Healthcare · $7.9M mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

31/ 100
No moat

The four filters

Pricing power28

Median gross margin 31.2% over 10y, variable.

Returns on capital14

Median ROIC -3.1%, above the 9% hurdle in 40% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline37

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale
No price data
Owner earnings (normalized)
—
Est. intrinsic value / share
—
Recent price
$0.50
Discount to value
No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

12 years of fundamentals

The business, in plain English

Quarta-Rad, Inc. booked $244955 of revenue in FY2025 in the Healthcare sector and kept 41.5% of it as gross profit — a solid-margin business by that measure. After every other cost, −104.9% of each revenue dollar reached the bottom line.

Across the filed record, revenue shrank from $829032 (FY2015) to $244955 (FY2025) — about −11.5% a year compounded over 10 years.

It earned −450.7% on invested capital in FY2025, with a median of −3.1% across 5 filed years. The Returns on Capital filter above scores it 14/100.

QURT's filings don't disclose total debt in a form the methodology can use, so leverage is treated as unmeasured — never assumed to be zero.

The share count rose 6.0% between FY2015 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 37/100.

Put together: Balance-Sheet Safety is the strongest of the four filters (55/100) and Returns on Capital the weakest (14/100), which is how QURT lands at 31/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2014–FY2025 · 12 fiscal years, normalized from QURT’s SEC filings

RevenueSales, as filed$244955 FY2025
$0$500000$1M2014201820222025
Gross marginRevenue kept after cost of goods41.5% FY2025
0%20%40%2014201820222025
Return on invested capitalOperating profit on the capital employed−450.7% FY2025
−500%0%2014201820222025
Owner earningsCash an owner could take out−$216755 FY2024
−$500000$02014201820222025

Gaps in a line mean that item isn’t in QURT’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

4 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale30.9 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026Jul 18, 2026

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — QURT has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Track record

How Quarta-Rad, Inc.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

As-of scores 2016–2025, one methodology version · reconstructed from filings on file each Dec 31 — never with hindsight

As-of Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored QURT on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

0406080100WideNarrowShallowNo moatAs-of Moat Score2050100Indexed price · log scale (2019 = 100)201620182020202220242026

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, QURT did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Healthcare context

#358 of 461 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #356URGN UroGen Pharma Ltd.31.3No moat
  2. #357LCTC LIFELOC TECHNOLOGIES, INC.30.9No moat
  3. #359IRIX IRIDEX CORP30.5No moat
  4. #360SPAI Safe Pro Group Inc.30.3No moat

Compare QURT with its nearest peers →All Healthcare companies on the Index →

Common questions about QURT

Does Quarta-Rad, Inc. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores Quarta-Rad, Inc. (QURT) 30.9 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 28, returns on capital 14, balance-sheet safety 55, capital discipline 37.
How has QURT's Moat Score changed over time?
The record logs 4 readings since Jul 17, 2026; the latest reads 30.9 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows QURT’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/QURT"
  width="340" height="150" style="border:0"
  title="QURT Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell QURT. See the disclaimer.